Your browser doesn't support javascript.
loading
First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease.
Fukushima, K; Akagi, K; Kondo, A; Kubo, T; Sakamoto, N; Mukae, H.
Afiliación
  • Fukushima K; Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan. Electronic address: kiyofuku@isahaya.jrc.or.jp.
  • Akagi K; Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.
  • Kondo A; Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.
  • Kubo T; Department of Laboratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.
  • Sakamoto N; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Pulmonology ; 28(1): 6-12, 2022.
Article en En | MEDLINE | ID: mdl-34362702
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar / Prueba de Tuberculina / Ensayos de Liberación de Interferón gamma Tipo de estudio: Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Pulmonology Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar / Prueba de Tuberculina / Ensayos de Liberación de Interferón gamma Tipo de estudio: Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Pulmonology Año: 2022 Tipo del documento: Article